Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction?

Project Information

EVERREST

Grant agreement ID: 305823

Project closed

Start date 1 January 2013

End date 31 December 2018

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 754 709,33

EU contribution € 5 998 984,00

Coordinated by

UNIVERSITY COLLEGE LONDON
United Kingdom